Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Thill, Marc; Liedtke, Cornelia; Solomayer, Erich-Franz et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017BREAST CARE. Bd. 12. H. 3. 2017 S. 184-191
Makris, Georgios-Marios; Marinelis, Alexandros; Battista, Marco-Johannes et al.
An ovarian mass after breast cancer: Metachronous carcinoma or metastasis? A case reportINTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. Bd. 31. 2017 S. 106-108
Fasching, Peter A.; Grischke, Eva -Maria; Schuetz, Florian et al.
Analysis of everolimus starting dose as prognostic marker in HR plus mBC patients treated with everolimus (EVE) plus exemestane (EXE): Results of the 3rd interim analysis of the non-interventional trial BRAWO.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Frees, Sebastian; Kamal, Mohammed; Nestler, Sebastian et al.
ARE THE CURRENT FOLLOW-UP GUIDELINES AFTER TREATMENT FOR ORGAN CONFINED RENAL CANCER SUFFICIENT?JOURNAL OF UROLOGY. Bd. 197. H. 4. 2017 S. E914-E914
Moebus, Volker; Hell, Susanne; Schmidt, Marcus
Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 77. H. 10. 2017 S. 1079-1087
Maurer, S.; Elger, T.; Krajnak, S. et al.
AXILLARY SCHWANNOMA IMITATING AXILLARY CYSTINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1298-1298
Battista, M. J.; Schanz, V.; Schmidt, M. et al.
CHANGES OF THE THERAPEUTIC APPROACHES FOR ENDOMETRIAL CANCER PATIENTS IN GERMANY SINCE 2006INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1041-1041
Bayani, Jane; Kornaga, Elizabeth; Crozier, Cheryl et al.
Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Baumann, F. T.; Hasenburg, A.; Jahn, P. et al.
Excercise is medicine in oncology. On the way to becoming a standard pillar in the treatment of cancer patientsONKOLOGE. Bd. 23. H. 12. 2017 S. 1021-1030
Eckes, L.; Harter, P.; Muallem, M. Z. et al.
FIRST RESULTS OF THE GERMAN PROSPECTIVE REGISTRY FOR GYNECOLOGICAL SARCOMAS (REGSA): A COLLABORATION OF NOGGO, AGO STUDY GROUP, AGO KOMMISSION OVAR, AGO KOMMISSION UTERUS, AROINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1323-1323